Crohn's disease: Ustekinumab induces rapid symptom reduction

被引：0
|
作者：
Simon, Annika
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2024年 / 62卷 / 05期
关键词：
D O I：
10.1055/a-2253-5211
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Ustekinumab ist ein humaner monoklonaler IgG1 kappa -Antikorper gegen Interleukin (IL)-12/23 und ist zur Behandlung von Autoimmunerkrankungen wie Psoriasis und Morbus Crohn (MC) indiziert. Da die Ustekinumab-Reaktionsdynamik fur MC-PatientInnen im Rahmen der Therapieplanung meist eine besondere Rolle spielt, haben Colombel et al. diese auf Basis der Daten mehrerer MC-Studien einmal genauer betrachtet.
引用
收藏
页码：699 / 701
页数：2
相关论文
共 50 条
  • [41] Ustekinumab: a novel therapeutic option in Crohn's disease
    Simon, E. G.
    Samuel, S.
    Ghosh, S.
    Moran, G. W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (08) : 1065 - 1074
  • [42] Intensification with Intravenous Ustekinumab in Refractory Crohn's Disease
    Ferrer, Cristina Suarez
    Arguelles, Jose Arroyo
    Garcia, Jose Luis Rueda
    Ramirez, Laura Garcia
    Arranz, Eduardo Martin
    Azofra, Maria Sanchez
    Cordon, Joaquin Poza
    Belda, Jesus Noci
    Martin-Arranz, Maria Dolores
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [43] Ustekinumab as an Induction Agent for Crohn's Disease of the Pouch
    Singh, Amandeep
    Ghouri, Yezaz
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (05) : E12 - E13
  • [44] USTEKINUMAB DOSE INTENSIFICATION IN PAEDIATRIC CROHN'S DISEASE
    Rodriguez-Mauriz, Rosa
    Segui Solanes, Carlos
    Masiques Mas, Isabel
    Rudi Sola, Nuria
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (07) : 1149 - 1149
  • [45] EFFICACY OF DOSE INTENSIFICATION OF USTEKINUMAB IN CROHN'S DISEASE
    Ramaswamy, Pradeep Kakkadasam
    Moattar, Hadi
    Sawyer, Elise A.
    James, Rayshelle
    Edwards, John
    Shukla, Dheeraj
    GASTROENTEROLOGY, 2020, 158 (06) : S956 - S956
  • [46] Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease
    Li, Katherine
    Friedman, Joshua R.
    Chan, Daphne
    Pollack, Paul
    Yang, Feifei
    Jacobstein, Douglas
    Brodmerkel, Carrie
    Gasink, Christopher
    Feagan, Brian G.
    Sandborn, William J.
    Rutgeerts, Paul
    De Hertogh, Gert
    GASTROENTEROLOGY, 2019, 157 (04) : 1019 - +
  • [47] Ustekinumab in Crohn's Disease: A Single Tertiary Centre's Experience
    Murphy, E.
    Chan, G.
    Mullen, A.
    Leyden, J.
    MacMathuna, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S275 - S276
  • [48] Chronic inflammatory Bowel Diseases Ustekinumab in Crohn's disease?
    Pommer, Peter
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (06): : 523 - 523
  • [49] Tolerability of Ustekinumab in Induction and Maintenance for the Treatment of Crohn's Disease
    Edward, Loftus Jr
    Bernie, Sattin
    Douglas, Jacobstein
    Christopher, Gasink
    Sheldon, Sloan
    Brian, Feagan
    Jean-Frederic, Colombel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S23 - S24
  • [50] Ustekinumab in Crohn's disease: evidence to date and place in therapy
    Engel, Tal
    Kopylov, Uri
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (04) : 208 - 214
12345